Vaccines 2016: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others)
Vaccines: The World Market analyzes the revenues for vaccines used in humans to prevent various types of disease. The report provides a comprehensive revenue summary, including revenue growth of vaccines vs. pharmaceuticals, 2013-2022; global market for vaccines by type, pediatric vs. adult, 2013-2022; global vaccines revenues by vaccine type, 2013-2022 (pediatric: combinations, hepatitis, HIB, MMR, pneumococcal, poliovirus, varicella, others; adult: cervical cancer, hepatitis, influenza, pneumococcal, travel – DT – misc., total); global vaccines revenues by geographic region, 2013-2022 (U.S., North America / Caribbean, South America, EU, Japan, India, China, rest of world, total); major companies’ shares of the global vaccine market, 2015; 2015 global vaccines revenues, by leading competitors; major companies’ shares of the global pediatric vaccine market, 2015; and major companies’ shares of the global adult vaccine market, 2015.
This market review concentrates on commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable, with a discussion of selected emerging vaccines for diseases that are not currently vaccine-preventable, such as addiction and malaria. Further, the report analyzes the developing and current pediatric preventive vaccines market, as well as examining in detail the adult preventative vaccines market. GlaxoSmithKline, Merck & Co., Pfizer, and Sanofi Pasteur are among the dominant companies whose vaccine offerings are reviewed in-depth.